Skip to main content

Table 1 Comparison of clinicopathological parameters between CD133 and CD133+ ICC patients

From: CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma

  CD133 (n = 27) CD133+ (n = 30) P
Age 57.4 ± 8.4 60.5 ± 11.5 0.47
Gender    0.76
 Male 19 (70.3%) 20 (66.7%)  
 Female 8 (29.7%) 10 (33.3%)  
TNM stages    
 T    0.37
  1–2 14 (51.9%) 12 (40.0%)  
  3–4 13 (48.1%) 18 (60.0%)  
 N    0.41
  0 19 (70.4%) 18 (60.0%)  
  1 8 (29.6%) 12 (40.0%)  
 M    0.03
  0 24 (88.9%) 19 (63.3%)  
  1 3 (10.1%) 11 (36.7%)  
Differentiation    0.89
 1–2 14 (51.9%) 15 (50.0%)  
 3–4 13 (48.1%) 15 (50.0%)  
Recurrence    0.02
 0 10 (35.7%) 3 (10.0%)  
 1 18 (64.3%) 27 (90.9%)